EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma

European Association for the Study of the Liver

doi:10.1016/j.jhep.2018.03.019

EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma

European Association for the Study of the Liver

Research output: Contribution to journal › Article › peer-review

6182 Scopus citations

Original language	English
Pages (from-to)	182-236
Number of pages	55
Journal	Journal of Hepatology
Volume	69
Issue number	1
DOIs	https://doi.org/10.1016/j.jhep.2018.03.019
State	Published - Jul 2018

Access to Document

10.1016/j.jhep.2018.03.019

Cite this

@article{da122c3bd1fd4e8092d32aa7e52ae3cc,

title = "EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma",

author = "{European Association for the Study of the Liver} and Galle, {Peter R.} and Alejandro Forner and Llovet, {Josep M.} and Vincenzo Mazzaferro and Fabio Piscaglia and Raoul, {Jean Luc} and Peter Schirmacher and Val{\'e}rie Vilgrain",

note = "Funding Information: Peter R. Galle reports grant/research support from Bayer, Eli Lilly, BMS, MSD, SillaJen, Merck, Blueprint Medicines, Arqule, Gilead, AbbVie, WAKO; consultant/advisory roles with Bayer, Eli Lilly, BMS; sponsored lectures for Bayer, Lilly, WAKO. Fabio Piscaglia reports grant/research support from ESAOTE; consultant/advisory roles for Bayer, Eisai; sponsored lectures for Bayer, Bracco, Meda Pharma. Jean-Luc Raoul reports consultant/advisory roles for Bayer SP, BTG, MSD; sponsored lectures for Bayer SP. Josep Llovet reports grant/research support from Bayer, Blueprint Medicines, Boehringer-Ingelheim, BMS; consultant/advisory roles for Bayer, BMS, Boehringer-Ingelheim, Eli Lilly, Celsion, Biocompatibles, Novartis, GlaxoSmithKline, Blueprint Medicines, Eisai, Tiziana Therapeutic, Guerbert; sponsored lectures for AEEH, APASL, AACR, AASLD, EASL, ILCA, Bayer. Peter Schirmacher reports grant/research support for Novartis; consultant/advisory roles for Novartis, MSD, BMS. Val{\'e}rie Vilgrain reports grant/research support from Sirtex; consultant/advisory roles for Guerbet; sponsored lectures for Supersonic, Bracco, Guerbet; Sirtex. Vincenzo Mazzaferro reports being on the advisory board of a BTG Inc. sponsored trial that failed recruitment; sponsored lectures for Bayer Italy; involvement in phase III RCTs for BMS and Arqule. Please refer to the accompanying ICMJE disclosure forms for further details. ",

year = "2018",

month = jul,

doi = "10.1016/j.jhep.2018.03.019",

language = "English",

volume = "69",

pages = "182--236",

journal = "Journal of Hepatology",

issn = "0168-8278",

publisher = "Elsevier",

number = "1",

}

TY - JOUR

T1 - EASL Clinical Practice Guidelines

T2 - Management of hepatocellular carcinoma

AU - European Association for the Study of the Liver

AU - Galle, Peter R.

AU - Forner, Alejandro

AU - Llovet, Josep M.

AU - Mazzaferro, Vincenzo

AU - Piscaglia, Fabio

AU - Raoul, Jean Luc

AU - Schirmacher, Peter

AU - Vilgrain, Valérie

N1 - Funding Information: Peter R. Galle reports grant/research support from Bayer, Eli Lilly, BMS, MSD, SillaJen, Merck, Blueprint Medicines, Arqule, Gilead, AbbVie, WAKO; consultant/advisory roles with Bayer, Eli Lilly, BMS; sponsored lectures for Bayer, Lilly, WAKO. Fabio Piscaglia reports grant/research support from ESAOTE; consultant/advisory roles for Bayer, Eisai; sponsored lectures for Bayer, Bracco, Meda Pharma. Jean-Luc Raoul reports consultant/advisory roles for Bayer SP, BTG, MSD; sponsored lectures for Bayer SP. Josep Llovet reports grant/research support from Bayer, Blueprint Medicines, Boehringer-Ingelheim, BMS; consultant/advisory roles for Bayer, BMS, Boehringer-Ingelheim, Eli Lilly, Celsion, Biocompatibles, Novartis, GlaxoSmithKline, Blueprint Medicines, Eisai, Tiziana Therapeutic, Guerbert; sponsored lectures for AEEH, APASL, AACR, AASLD, EASL, ILCA, Bayer. Peter Schirmacher reports grant/research support for Novartis; consultant/advisory roles for Novartis, MSD, BMS. Valérie Vilgrain reports grant/research support from Sirtex; consultant/advisory roles for Guerbet; sponsored lectures for Supersonic, Bracco, Guerbet; Sirtex. Vincenzo Mazzaferro reports being on the advisory board of a BTG Inc. sponsored trial that failed recruitment; sponsored lectures for Bayer Italy; involvement in phase III RCTs for BMS and Arqule. Please refer to the accompanying ICMJE disclosure forms for further details.

PY - 2018/7

Y1 - 2018/7

UR - http://www.scopus.com/inward/record.url?scp=85045123425&partnerID=8YFLogxK

U2 - 10.1016/j.jhep.2018.03.019

DO - 10.1016/j.jhep.2018.03.019

M3 - Article

C2 - 29628281

AN - SCOPUS:85045123425

SN - 0168-8278

VL - 69

SP - 182

EP - 236

JO - Journal of Hepatology

JF - Journal of Hepatology

IS - 1

ER -